Sanara MedTech
SMTI
52 hedge funds and large institutions have $31.4M invested in Sanara MedTech in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 5 closing their positions.
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
11% more capital invested
Capital invested by funds: $28.3M → $31.4M (+$3.13M)
6% more funds holding
Funds holding: 49 → 52 (+3)
2.15% more ownership
Funds ownership: 10.3% → 12.45% (+2.2%)
11% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$1.27M |
| 2 |
BlackRock
New York
|
+$972K |
| 3 |
HSBC Holdings
London,
United Kingdom
|
+$402K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$277K |
| 5 |
Millennium Management
New York
|
+$248K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$614K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$330K |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$326K |
| 4 |
Squarepoint
New York
|
-$257K |
| 5 |
Goldman Sachs
New York
|
-$203K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TWD
51
True Wealth Design
Akron,
Ohio
| $57 | – | – | – |
|
|
EP
52
Essential Partners
Rancho Santa Fe,
California
| $57 | +$60 | +2 | New |
|
|
IA
53
IFP Advisors
Tampa,
Florida
| $56 | – | – | – |
|
|
N
54
Nuveen
Charlotte,
North Carolina
| – | -$326K | -10,565 | Closed |
|
|
55
Goldman Sachs
New York
| – | -$203K | -6,581 | Closed |
|
|
MIM
56
MetLife Investment Management
Whippany,
New Jersey
| – | -$82K | -2,656 | Closed |
|
|
CF
57
Corebridge Financial
Houston,
Texas
| – | -$61.3K | -1,985 | Closed |
|
|
C
58
Covestor
London,
United Kingdom
| – | -$1K | -21 | Closed |
|
SMTI Hedge Fund Activity: Q2 2025 in Review
52 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q2 2025, worth a combined $31.4M — up 11% from $28.3M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new SMTI positions and 5 closed out — a net gain of 3 holders — while 17 added to existing stakes and 19 trimmed.
The largest buyer was Marshall Wace, adding an estimated $1.27M. The largest seller was Vanguard Group, cutting an estimated $614K.
- 52 institutional investors held Sanara MedTech (SMTI) as of Q2 2025, up from 49 in Q1 2025.
- Funds reported $31.4M of Sanara MedTech stock for Q2 2025, up 11% quarter-over-quarter.
- 8 funds opened new Sanara MedTech positions in Q2 2025 and 5 closed out, a net change of +3 holders.
- The largest Sanara MedTech buyer in Q2 2025 was Marshall Wace, an estimated $1.27M added.
- The largest Sanara MedTech seller in Q2 2025 was Vanguard Group, an estimated $614K sold.
Based on aggregated 13F filings for Q2 2025.